The SLC22A7 gene gives cells instructions for a transport protein that moves certain waste products, natural body chemicals, and some medicines across cell membranes, mainly in the liver and kidneys. This gene helps your body handle compounds that need to be processed or cleared. If it works less well, your body may handle some substances and drugs differently. The SLC22A7 gene is mainly discussed in medical research rather than public culture.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes hold the instructions for making proteins, the parts of cells that do the work. Others mainly help control when certain processes happen, where they happen, and how strongly they operate. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. If you want to look into this subject more deeply, you can find more in the LearnHub.
Overview
SLC22A7Gene function
What if the gene works
The SLC22A7 gene helps liver and kidney cells move certain body chemicals, waste products, and some medicines across cell membranes. This supports the body’s normal handling and clearing of these substances.
Risk
What if the gene does not work
Changes in the SLC22A7 gene can range from milder to more severe and may reduce how well liver and kidney cells move certain organic acids, bile compounds, and medicines across their membranes. This can alter normal cellular transport and clearance.
Treatment
What does that mean for your treatment
No treatment or management approach is currently established specifically for pathogenic variants in the SLC22A7 gene. The SLC22A7 gene is being studied for its role in moving some medicines through the body, which may later inform drug response research.
Gene function
What if the gene works
Many everyday compounds need the right doorway to move between blood and cells. In the liver and kidneys, the SLC22A7 gene helps provide one of those doorways for small negatively charged molecules (organic anions). This supports how your body handles waste products, natural body chemicals, and some medicines.
This protein sits in the cell membrane and moves small negatively charged molecules into cells. That controlled movement helps direct certain compounds to the next step in processing or removal.
In kidney cells, the SLC22A7 gene helps take selected compounds out of the blood and into the urine forming pathway. This supports normal clearing of everyday waste and body made chemicals.
In liver cells, it helps bring in compounds that need to be changed, reused, or prepared for clearance. This is part of how your body handles medicines and waste products.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help make up normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental factors. Many variants do not lead to any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can more strongly change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Research on how variants influence the SLC22A7 gene's function shows that many changes alter the OAT2 transporter’s shape, stability, or placement in the cell membrane. Some variants mildly reduce how well the transporter moves small charged molecules, while more severe variants can sharply lower transport activity or keep the protein from reaching the cell surface. These differences can lead to partial or near-complete loss of function at the cellular level.
How variants are linked to conditions
At present, the SLC22A7 gene does not yet have a broadly confirmed link to a specific inherited health condition, though research on how SLC22A7 gene variants are linked to conditions is still evolving. If you have a reported variant in the SLC22A7 gene, your doctor or genetic counselor can interpret it in the context of your personal health and family history.
A variant is not necessarily a diagnosis
Variants in genes are a normal feature of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when more than one gene and environmental factors also play a role. In some situations, though, a single well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC22A7 gene. Some changes in this gene may affect how the body handles certain substances or medicines, but this does not translate into a clear, general risk pattern for most people.
Inheritance of SLC22A7 variants
There is not yet a broadly confirmed Mendelian pattern for how SLC22A7 gene variants are inherited in relation to a specific human genetic condition. In practice, discussion of SLC22A7 gene variant inheritance remains cautious because current evidence has not established a single disease specific pattern such as autosomal dominant or autosomal recessive. The SLC22A7 gene is located on chromosome 6, which is an autosome, so each person inherits one copy from each parent.
What does my SLC22A7 result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific health condition for the SLC22A7 gene, though this can change as research develops. If you have a specific SLC22A7 result and questions about what it could mean for your family, a doctor or genetic counselor can help explain it in the context of your relatives and health history.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change, a lab can do testing for SLC22A7 gene variants using DNA from a blood sample, saliva, or a cheek swab. It reads the SLC22A7 gene’s code and compares it with a standard reference to identify variants and help classify them as benign, uncertain, or clinically relevant.
When should I consider getting a genetic test?
There is not yet a broadly established, SLC22A7-specific reason to get genetic testing in routine care. Decisions about testing are usually based on your personal health and family history and are best discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it can tell you varies based on the condition and the kind of variant. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down, move, or clear a drug differently, so the same dose may work better for one person and less well for another. These inherited differences are common and can influence both benefit and side effects. Medication response also depends on other factors, including age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences can shape a person’s response to medications. By examining links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes affect how strongly a drug works or how the body processes it. This information can support more informed, individualized treatment decisions. To explore this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the SLC22A7 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, new medicines, or treatment changes are best discussed with your doctor.
History
Researchers identified the SLC22A7 gene in the late 1990s as part of a broader effort to map a family of transport genes active in the liver and kidneys. Early studies placed it within the solute carrier 22 group, alongside related genes that drew attention for their role in moving small molecules through cells. As medical science evolved, so did understanding of this gene. Work in the 2000s helped distinguish SLC22A7 from nearby relatives by showing that it had its own tissue pattern and transport profile. Its history is mainly tied to the wider rise of transporter biology, when scientists were sorting out how the body handles natural waste products and many medicines.